PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33397455-2	2021	FDA approval of Ivosidenib and Enasidenib, small molecule inhibitors of isocitrate dehydrogenase enzymes (IDH1 and 2) have opened new avenues of treatment.	enasidenib	31-41	isocitrate dehydrogenase (NADP(+)) 1	Homo sapiens	106-116